Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures

International Journal of Gynecological Cancer

Volumn 16, Issue 2, 2006, Pages 490-495

  Tentes, A A K ^a   Mirelis, C G ^a   Markakidis, S K ^a   Bekiaridou, K A ^a   Bougioukas, I G ^a   Xanthoulis, A I ^a   Tsalkidou, E G ^a   Zafiropoulos, G H ^a   Nikas, I H ^a  

^a Didimotichon General Hospital   (Greece)

Author keywords

Cytoreductive surgery; Ovarian cancer; Standard peritonectomy procedures

Indexed keywords

DOCETAXEL; FLUOROURACIL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; TUMOR MARKER;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CARCINOMATOUS PERITONITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; ILEUS; KARNOFSKY PERFORMANCE STATUS; KIDNEY FAILURE; LUNG EMBOLISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OVARY CARCINOMA; PANCREATITIS; PERITONECTOMY; PERITONEUM; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; URINARY TRACT INFECTION;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; FEMALE; HOSPITAL MORTALITY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646045037     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00580.x     Document Type: Article

References (24)

1. Randall T Rubin S Cytoreductive surgery for ovarian cancer Surg Clin North Am 2001 81 871 83
2. Bristow R Tomacruz R Armstrong D Trimble E Montz F Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 2002 20 1248 59
3. Begossi G Gonzalez-Moreno S Ortega-Perez G Fon L Sugarbaker P Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis, and mesothelioma Eur J Surg Oncol 2002 28 80 7
4. Sugarbaker P Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology In Sugarbaker P ed Peritoneal carcinomatosis: principles of management Boston, MA Kluwer Academic Publishers 1996 80 100
5. Chi D Franklin C Levine D et al Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol 2004 94 650 4
6. Jacqeut P Sugarbaker P Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis In Sugarbaker PH ed Peritoneal carcinomatosis: principles of management Boston, MA Kluwer Academic Publishers 1996 359 74
7. Sugarbaker P Peritonectomy procedures Ann Surg 1995 221 29 42
8. Michel G Zarca D Castaigne D Prade M Secondary cytoreductive surgery in ovarian cancer Eur J Surg Oncol 1989 15 201 4
9. Neijt J Ovarian cancer: rethinking prognostic factors and chemotherapy ASCO Educational Book, 30th Annual Meeting, AMGEN, Inc (ed.) 1994 214 20
10. Memarzadeh S Berek J Advances in the management of epithelial ovarian cancer J Reprod Med 2001 46 621 9
11. Look M Chang D Sugarbaker P Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum Int J Gynecol Cancer 2004 14 35 41
12. Piso P Dahlke M-H Loss M Juergen H Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer World J Surg Oncol 2004 2 21
13. Tentes AA Tripsiannis G Markakidis S et al Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer Eur J Surg Oncol 2003 29 69 73
14. Friedlander M Prognostic factors in ovarian cancer Semin Oncol 1998 25 305 15
15. Stamou K Karakozis S Sugarbaker P Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer J Surg Oncol 2003 83 197 203
16. Roberts W Cytoreductive surgery in ovarian cancer: why, when, and how? Cancer Control 1996 3 130 6
17. Parazzini F Valsecchi G Bolis G et al Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival Gynecol Oncol 1999 74 7 11
18. Isonishi S Niimi S Sasaki H Ochiai K Yasuda M Tanaka T Drug-sensitivity related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIC and IV ovarian cancer Gynecol Oncol 2004 93 647 52
19. Martinez-Said H Rincon D Montes de Oca M Ruiz G Ponce J Lopez-Graniel C Predictive factors for irresectability in advanced ovarian cancer Int J Gynecol Cancer 2004 14 423 30
20. Elias D Sideris L Pocard M et al Results of R0 resection for colorectal liver metastases associated with extrahepatic disease Ann Surg Oncol 2004 11 274 80
21. Sebbag G Sugarbaker P Peritoneal mesothelioma proposing for a staging system Eur J Surg Oncol 2001 27 223 4
22. Harmon R Sugarbaker P Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer Int Semin Surg Oncol 2005 2 3
23. Petignat P Fioretta G Verkooijen H et al Poorer survival of elderly patients with ovarian cancer: a population-based study Surg Oncol 2004 13 181 6
24. Stephens A Alderman R Chang D et al A mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with the Coliseum technique Ann Surg Oncol 2000 6 790 6